Page 1

• Enzo Biochem Reports First Quarter 2022 Financial Results and Provides Business Update December 15 , 2021 Enzo • 1Q FY 2022 revenues of $ 26.5 million vs. $ 24.8 million in 4Q FY 2021 , representing a 7 % sequential increase • Company appoints Hamid Erfanian as Chief Executive Officer • Consolidated manufacturing footprint at state - of - the - art Farmingdale , NY campus to enhance operational efficiencies Conference call and live webcast scheduled for today , Wednesday , December 15 , 2021 at 4:30 pm ( ET ) NEW YORK , Dec. 15 , 2021 ( GLOBE NEWSWIRE ) -- Enzo Biochem , Inc. ( NYSE : ENZ ) , a leading biosciences and diagnostics company , today reported financial results for the first quarter ended October 31 , 2021 and provided a business update on recent corporate and operational developments . This quarter once again reflects Enzo's continued progress in advancing its strategic business plan . Hamid Erfanian recently joined Enzo as Chief cutive fficer and is poised to lead the Company and accelerate the expansion and commercialization strategies of its platforms and services . Mr. Erfanian brings 28 years of experience as a seasoned healthcare executive specializing in the diagnostic , medical devices , and life sciences industries . He has a proven track record of implementing successful commercial strategies and building high performing teams at both global and smaller firms . He comes to Enzo from his prior role as Chief Commercial Officer of EUROIMMUN , a PerkinElmer Company , where he was responsible for growing sales by more than 20 - fold in seven years . " I am honored to have joined the Enzo team at a very exciting and promising stage in the Company's growth . I look forward to applying my experience in diagnostics to maximize the commercial potential of the GENFLEX® platform and all of Enzo's world class assets and technologies , " said Hamid Erfanian , Chief Executive Officer of Enzo . " Since joining Enzo Biochem , I have formed a deeper understanding of the Company's many significant business opportunities . I have been continually impressed and proud of the level of dedication , integrity and perseverance demonstrated at every part of the organization . COVID - 19 has been difficult for all of us . While the world was in lockdown , our team of industry leaders remained on the frontlines and delivered growth . COVID has shed a new